ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Pharmaron (UK) Investments Limited

Pharmaron (UK) Investments Limited is an active company incorporated on 1 October 2020 with the registered office located in Altrincham, Greater Manchester. Pharmaron (UK) Investments Limited was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12919983
Private limited company
Age
5 years
Incorporated 1 October 2020
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 30 September 2025 (1 month ago)
Next confirmation dated 30 September 2026
Due by 14 October 2026 (11 months remaining)
Last change occurred 28 days ago
Accounts
Submitted
For period 1 Jan31 Dec 2023 (12 months)
Accounts type is Full
Next accounts for period 31 December 2024
Due by 31 December 2025 (1 month remaining)
Address
3rd Floor 1 Ashley Road
Altrincham
Cheshire
WA14 2DT
United Kingdom
Same address for the past 4 years
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
2
Shareholders
1
Controllers (PSC)
3
PSC • Director • American • Lives in United States • Born in Sep 1963
Director • Hong Konger • Lives in China • Born in Oct 1978
Xiaoqiang Lou
PSC • Chinese • Lives in China • Born in Aug 1968
Bei Zheng
PSC • Chinese • Lives in China • Born in Jul 1967
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Pharmaron Biologics (UK) Holdings Limited
Dr Boliang Lou and Gilbert Shing Chung Li are mutual people.
Active
Pharmaron Manufacturing Services (UK) Ltd
Dr Boliang Lou is a mutual person.
Active
Quotient Bioresearch (Radiochemicals) Limited
Dr Boliang Lou is a mutual person.
Active
Pharmaron UK Limited
Dr Boliang Lou is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2021–2023)
Period Ended
31 Dec 2023
For period 31 Dec31 Dec 2023
Traded for 12 months
Cash in Bank
£26K
Decreased by £32K (-55%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£152.27M
Decreased by £8.87M (-6%)
Total Liabilities
£0
Decreased by £826K (-100%)
Net Assets
£152.27M
Decreased by £8.04M (-5%)
Debt Ratio (%)
0%
Decreased by 0.51% (-100%)
Latest Activity
Confirmation Submitted
28 Days Ago on 13 Oct 2025
Confirmation Submitted
1 Year Ago on 14 Oct 2024
Full Accounts Submitted
1 Year 1 Month Ago on 2 Oct 2024
Compulsory Strike-Off Discontinued
1 Year 8 Months Ago on 13 Mar 2024
Compulsory Gazette Notice
1 Year 8 Months Ago on 12 Mar 2024
Dr. Boliang Lou (PSC) Details Changed
3 Years Ago on 7 Jan 2022
Dr. Boliang Lou (PSC) Details Changed
3 Years Ago on 7 Jan 2022
Bei Zheng (PSC) Appointed
4 Years Ago on 2 Dec 2020
Xiaoqiang Lou (PSC) Appointed
4 Years Ago on 2 Dec 2020
Boliang Lou (PSC) Appointed
4 Years Ago on 2 Dec 2020
Get Credit Report
Discover Pharmaron (UK) Investments Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 30 September 2025 with updates
Submitted on 13 Oct 2025
Change of details for Dr. Boliang Lou as a person with significant control on 7 January 2022
Submitted on 2 Oct 2025
Change of details for Dr. Boliang Lou as a person with significant control on 7 January 2022
Submitted on 1 Oct 2025
Notification of Xiaoqiang Lou as a person with significant control on 2 December 2020
Submitted on 29 Jul 2025
Withdrawal of a person with significant control statement on 29 July 2025
Submitted on 29 Jul 2025
Notification of Bei Zheng as a person with significant control on 2 December 2020
Submitted on 29 Jul 2025
Notification of Boliang Lou as a person with significant control on 2 December 2020
Submitted on 29 Jul 2025
Statement of capital following an allotment of shares on 31 December 2024
Submitted on 14 Jan 2025
Confirmation statement made on 30 September 2024 with no updates
Submitted on 14 Oct 2024
Full accounts made up to 31 December 2023
Submitted on 2 Oct 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year